Subcutaneous Catheter for IVF Stimulation in Female Infertility

Palo Alto (17 mi)

Overseen byRichard J Paulson, MD

Age: 18 - 65

Sex: Female

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: N/A

Recruiting

Sponsor: University of Southern California

No Placebo Group

Trial Summary

What is the purpose of this trial?This trial is testing a small tube placed under the skin to deliver medication for IVF patients. It aims to reduce the physical and emotional burden of frequent injections by providing continuous medication delivery. The study will check safety, patient satisfaction, and IVF outcomes.

Eligibility Criteria

This trial is for women aged 18 to 45 who are undergoing controlled ovarian stimulation as part of in-vitro fertilization (IVF) treatment. There are no specific exclusion criteria mentioned, so it appears open to all women within this age range and treatment category.

Treatment Details

The study is testing the use of the Neria™ Guard Subcutaneous Catheter during IVF treatments. The goal is to see if using this catheter can make taking medications easier and less stressful compared to daily injections typically used in these procedures.

1Treatment groups

Experimental Treatment

Group I: IVF with Neria™ Guard deviceExperimental Treatment1 Intervention

Patients undergoing IVF with the use of the Neria™ Guard subcutaneous catheter